Page tree

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

  1. Continue testing Quality Measurement use cases.
    1. Evaluate FHIR-based eCQMs written with CQL.
    2. Test eCQM structure, packaging, and reference libraries from draft MAT on FHIR export packages.
    3. Test and validate the use of the QI-Core model in CQL authoring.
    4. Test supplemental data use cases for eCQMs.
    5. Test continuous variable and stratified eCQMs.
  2. Test the use of FHIR resources in alignment with FHIR R4 Implementation Guides (IG).
    1. QI-Core IG.
    2. Quality Measure IG.
    3. Data Exchange for Quality Measures (DEQM) IG.
  3. Test FHIR Clinical Guidelines example content (in coordination with the Care Planning and Public Health tracks).
  4. Test the new `order-select` hook using CDC Opioid Prescribing (in coordination with the CDS Hooks track).

  5. Conduct end-to-end testing: identify a gap, close gap and report measure, specifically Breast Cancer Screening--CMS 125v8 or v9 (in coordination with the DaVinci DEQM Gaps in Care track)
  6. Continue investigation of bulk import support.

  7. Test the ExecutableLibrary profile.

  8. Test the following CMS Measures for R4

Eligible Professional (EP)/Eligible Clinician (EC) Measures
2019 Reporting Measures

2020 Reporting Measures

2021 Reporting Measures

Other Measures for Consideration

  • CMS130v7: Colorectal Cancer Screening
  • CMS165v8: Controlling High Blood Pressure
  • CMS349v2: HIV Screening
  • CMS124v8: Cervical Cancer Screening
  • CMS125v8: Breast Cancer Screening
  • CMS74v10: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
  • CMS124v9: Cervical Cancer Screening
  • CMS125v9: Breast Cancer Screening
  • CMS137v9: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
  • CMS153v9: Chlamydia Screening for Women
  • CMS347v4: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
  • CMS146v9:Appropriate Testing for Children with Pharyngitis
  • CMS154v9: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
  • CMS155v9: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
  • CMS159v9: Depression Remission at Twelve Months


Eligible Hospital (EH)/Critical Access Hospital (CAH) Measures

2020 Reporting Measures

2021 Reporting Measures

  • CMS104v8: Discharged on Antithrombotic Therapy
  • CMS105v8: Discharged on Statin Medication
  • CMS108v8: Venous Thromboembolism Prophylaxis
  • CMS111v9: Median Admit Decision Time to ED Departure Time for Admitted Patients
  • CMS506v3: Safe use of opioids - concurrent prescribing
  • CMS529v1: Hybrid Hospital-Wide Readmission

...